Biora Therapeutics Inc reports results for the quarter ended September 30 - Earnings Summary

• Biora Therapeutics Inc BIOR.OQ reported a quarterly adjusted loss of $5.04​​ per share for the quarter ended September 30, higher than the same quarter last year, when the company reported EPS of $-48.90. The mean expectation of two analysts for the quarter was for a loss of $3.85 per share. Wall Street expected results to range from $-4.20 to $-3.50 per share.

• Revenue was $32.00 thousand​; analysts expected $210.00 thousand.

• Biora Therapeutics Inc's reported EPS for the quarter was a loss of $5.04​.

• The company reported a quarterly loss of $18.4 million.

• Biora Therapeutics Inc shares had fallen by 52.6% this quarter and lost 82.4% so far this year.

FORECAST CHANGES

• The mean earnings estimate of analysts was unchanged in the last three months.​

• In the last 30 days, there have been no earnings estimate revisions by analysts covering the company.

RECOMMENDATIONS

• The current average analyst rating on the shares is "buy" and the breakdown of recommendations is 1 "strong buy" or "buy," no "hold" and no "sell" or "strong sell."

• The average consensus recommendation for the biotechnology & medical research peer group is also "buy"

Wall Street's median 12-month price target for Biora Therapeutics Inc is 97.50

This summary was machine generated from LSEG data November 15 at 02:01 p.m. UTC. ​All figures in US dollars unless otherwise stated. (For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact RefinitivNewsSupport@thomsonreuters.com)